Lilly (Eli) & Co (NYSE:LLY) on 10/15/2018 declared a dividend of $ 0.5625 per share payable on December 10, 2018 to shareholders of record as of November 15, 2018.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 2.04% and has increased its dividends for 3 successive years.

Lilly (Eli) & Co's market cap is $ 118,654,194,240 and has a PE ratio of 0.00. The stock price closed yesterday at $ 110.48 and has a 52 week low/high of $ 73.69 and $ 116.61.

Eli Lilly & Company is engaged in discovering, developing, manufacturing, and marketing products in two business segments: human pharmaceutical products and animal health products. Co.'s human pharmaceutical products include: endocrinology products, neurosciences products, oncology products, and cardiovascular products. Co.'s animal health products are comprised of products for animals, which include Rumensin, a cattle feed additive, and Tylan, an antibiotic used to control certain diseases in cattle, swine, and poultry; as well as products for companion animals, which include Trifexis and Comfortis, a chewable tablet that kills fleas and prevents flea infestations on dogs.

For more information on Lilly (Eli) & Co click here.